Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer

Clinical trial NCT02151721 · UNKNOWN

Trial details

NCT number: NCT02151721
Sponsor: Kanazawa University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small-Cell Lung Carcinoma

Start date: 2014-06-01
Primary completion: 2018-02-20
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.